Abstract
Background and aims: Fetuin-A has a plausible role in the inhibition of arterial calcification, but its association with risk of coronary heart disease (CHD) in the general population is unclear. We used two common genetic variants in the fetuin-A gene (AHSG) that are strongly associated with circulating fetuin-A levels to investigate the associations with risk of CHD and subclinical cardiovascular measures (intima-media thickness, ankle-arm index, and coronary artery calcification). Methods: Genetic variation and fetuin-A levels were assessed in 3299 community-living individuals (2733 Caucasians and 566 African Americans) 65 years of age or older, free of previous cardiovascular disease, who participated in the Cardiovascular Health Study (CHS) in 1992-1993. Results: Among Caucasians, both rs2248690 and rs4917 were associated with 12% lower fetuin-A concentrations per minor allele (P < 0.0001). The hazard ratios (HRs) per minor allele for incident CHD were 1.12 (95% CI: 1.00-1.26) for rs2248690 and 1.02 (0.91-1.14) for rs4917. Using both genotypes as an instrumental variable for measured fetuin-A, the HRs for one standard deviation increase in genetically determined fetuin-A levels on CHD risk were 0.84 (95% CI: 0.70-1.00) for rs2248690 and 0.97 (95% CI: 0.82-1.14) for rs4917, respectively. However, in CHS neither of the genotypes were associated with subclinical cardiovascular measures and when CHS data were meta-analyzed with data from six other prospective studies (totaling 26,702 Caucasian participants and 3295 CHD cases), the meta-analyzed HRs for incident CHD were 1.12 (0.93-1.34) and 1.06 (0.93-1.20) for rs2248690 and rs4917, respectively (p heterogeneity 0.005 and 0.0048). Conclusion: Common variants in the AHSG gene are strongly associated with fetuin-A levels, but their concurrent association with CHD risk in current prospective studies is inconsistent. Further investigation in studies with measured fetuin-A and AHSG variants is needed to clarify the potential causal association of fetuin-A with CHD risk.
| Original language | English (US) |
|---|---|
| Article number | 14245 |
| Pages (from-to) | 44-52 |
| Number of pages | 9 |
| Journal | Atherosclerosis |
| Volume | 243 |
| Issue number | 1 |
| DOIs | |
| State | Published - Nov 1 2015 |
Fingerprint
Keywords
- Coronary heart disease
- Fetuin-A
- Mendelian randomization
- Meta-analysis
- Single nucleotide polymorphisms
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Fetuin-A and risk of coronary heart disease : A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies. / Laugsand, Lars E.; Ix, Joachim H.; Bartz, Traci M.; Djousse, Luc; Kizer, Jorge; Tracy, Russell P.; Dehghan, Abbas; Rexrode, Kathryn; Lopez, Oscar L.; Rimm, Eric B.; Siscovick, David S.; O'Donnell, Christopher J.; Newman, Anne; Mukamal, Kenneth J.; Jensen, Majken K.
In: Atherosclerosis, Vol. 243, No. 1, 14245, 01.11.2015, p. 44-52.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Fetuin-A and risk of coronary heart disease
T2 - A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studies
AU - Laugsand, Lars E.
AU - Ix, Joachim H.
AU - Bartz, Traci M.
AU - Djousse, Luc
AU - Kizer, Jorge
AU - Tracy, Russell P.
AU - Dehghan, Abbas
AU - Rexrode, Kathryn
AU - Lopez, Oscar L.
AU - Rimm, Eric B.
AU - Siscovick, David S.
AU - O'Donnell, Christopher J.
AU - Newman, Anne
AU - Mukamal, Kenneth J.
AU - Jensen, Majken K.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - Background and aims: Fetuin-A has a plausible role in the inhibition of arterial calcification, but its association with risk of coronary heart disease (CHD) in the general population is unclear. We used two common genetic variants in the fetuin-A gene (AHSG) that are strongly associated with circulating fetuin-A levels to investigate the associations with risk of CHD and subclinical cardiovascular measures (intima-media thickness, ankle-arm index, and coronary artery calcification). Methods: Genetic variation and fetuin-A levels were assessed in 3299 community-living individuals (2733 Caucasians and 566 African Americans) 65 years of age or older, free of previous cardiovascular disease, who participated in the Cardiovascular Health Study (CHS) in 1992-1993. Results: Among Caucasians, both rs2248690 and rs4917 were associated with 12% lower fetuin-A concentrations per minor allele (P < 0.0001). The hazard ratios (HRs) per minor allele for incident CHD were 1.12 (95% CI: 1.00-1.26) for rs2248690 and 1.02 (0.91-1.14) for rs4917. Using both genotypes as an instrumental variable for measured fetuin-A, the HRs for one standard deviation increase in genetically determined fetuin-A levels on CHD risk were 0.84 (95% CI: 0.70-1.00) for rs2248690 and 0.97 (95% CI: 0.82-1.14) for rs4917, respectively. However, in CHS neither of the genotypes were associated with subclinical cardiovascular measures and when CHS data were meta-analyzed with data from six other prospective studies (totaling 26,702 Caucasian participants and 3295 CHD cases), the meta-analyzed HRs for incident CHD were 1.12 (0.93-1.34) and 1.06 (0.93-1.20) for rs2248690 and rs4917, respectively (p heterogeneity 0.005 and 0.0048). Conclusion: Common variants in the AHSG gene are strongly associated with fetuin-A levels, but their concurrent association with CHD risk in current prospective studies is inconsistent. Further investigation in studies with measured fetuin-A and AHSG variants is needed to clarify the potential causal association of fetuin-A with CHD risk.
AB - Background and aims: Fetuin-A has a plausible role in the inhibition of arterial calcification, but its association with risk of coronary heart disease (CHD) in the general population is unclear. We used two common genetic variants in the fetuin-A gene (AHSG) that are strongly associated with circulating fetuin-A levels to investigate the associations with risk of CHD and subclinical cardiovascular measures (intima-media thickness, ankle-arm index, and coronary artery calcification). Methods: Genetic variation and fetuin-A levels were assessed in 3299 community-living individuals (2733 Caucasians and 566 African Americans) 65 years of age or older, free of previous cardiovascular disease, who participated in the Cardiovascular Health Study (CHS) in 1992-1993. Results: Among Caucasians, both rs2248690 and rs4917 were associated with 12% lower fetuin-A concentrations per minor allele (P < 0.0001). The hazard ratios (HRs) per minor allele for incident CHD were 1.12 (95% CI: 1.00-1.26) for rs2248690 and 1.02 (0.91-1.14) for rs4917. Using both genotypes as an instrumental variable for measured fetuin-A, the HRs for one standard deviation increase in genetically determined fetuin-A levels on CHD risk were 0.84 (95% CI: 0.70-1.00) for rs2248690 and 0.97 (95% CI: 0.82-1.14) for rs4917, respectively. However, in CHS neither of the genotypes were associated with subclinical cardiovascular measures and when CHS data were meta-analyzed with data from six other prospective studies (totaling 26,702 Caucasian participants and 3295 CHD cases), the meta-analyzed HRs for incident CHD were 1.12 (0.93-1.34) and 1.06 (0.93-1.20) for rs2248690 and rs4917, respectively (p heterogeneity 0.005 and 0.0048). Conclusion: Common variants in the AHSG gene are strongly associated with fetuin-A levels, but their concurrent association with CHD risk in current prospective studies is inconsistent. Further investigation in studies with measured fetuin-A and AHSG variants is needed to clarify the potential causal association of fetuin-A with CHD risk.
KW - Coronary heart disease
KW - Fetuin-A
KW - Mendelian randomization
KW - Meta-analysis
KW - Single nucleotide polymorphisms
UR - http://www.scopus.com/inward/record.url?scp=84940904105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940904105&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2015.08.031
DO - 10.1016/j.atherosclerosis.2015.08.031
M3 - Article
VL - 243
SP - 44
EP - 52
JO - Atherosclerosis
JF - Atherosclerosis
SN - 0021-9150
IS - 1
M1 - 14245
ER -